FDA Import Refusal AEK-0832699-2/10002/1 — Intas Pharmaceuticals Limited
The FDA refused shipment AEK-0832699-2/10002/1 from Intas Pharmaceuticals Limited (India) on Aug 23, 2026. The refused product falls under Drugs and Biologics — TAMOXIFEN CITRATE (ANTI-ESTROGEN). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 23, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61UCA05 TAMOXIFEN CITRATE (ANTI-ESTROGEN)
- Charges
- 75